What is the current revenue of the erectile dysfunction device market?

The market revenue for erectile dysfunction device is anticipated at USD 2.18 Billion in 2027.

What is the forecasted size of the erectile dysfunction device industry?

Erectile Dysfunction Device Market size was assessed at USD 2.01 Billion in 2026 and is poised to grow at 9.86% CAGR between 2027 and 2036, surpassing USD 5.15 Billion by 2036.

What factors are accelerating adoption of device-based erectile dysfunction treatments?

Rising erectile dysfunction prevalence, greater acceptance of non-drug therapies, improved patient awareness, and increased physician guidance are encouraging more patients to adopt device-based treatment options across clinical and home-care settings.

How are product innovations influencing purchasing decisions in the erectile dysfunction device market?

Advancements in minimally invasive devices with ergonomic designs, improved safety, and enhanced usability are strengthening patient confidence, supporting treatment adherence, and expanding adoption among individuals seeking more comfortable long-term management solutions.

Why do non-surgical devices hold the largest share of the erectile dysfunction device market?

Non-surgical devices captured 60% of the market in 2026 because patients prefer minimally invasive, home-based treatment options that offer convenience, lower procedural risks, and improved user comfort.

Why is the more than 60 years age group the fastest-growing segment in the erectile dysfunction device market?

The more than 60 years age group is growing the fastest due to rising prevalence of age-related health conditions, longer life expectancy, improved access to specialized care, and greater focus on maintaining quality of life.

What makes North America the leading market for erectile dysfunction devices?

North America held 43.67% in 2026, supported by advanced healthcare infrastructure, specialist urological care, patient awareness, and demand for minimally invasive treatments.

Why is Asia Pacific expected to see the fastest growth in erectile dysfunction devices?

Asia Pacific is gaining momentum through improving urological healthcare access, rising awareness, healthcare investment, specialized services, and greater adoption of advanced therapeutic devices.

Which companies are driving growth in the erectile dysfunction device landscape?

Key companies in the erectile dysfunction device market include Boston Scientific Corporation (United States), Coloplast A/S (Denmark), Medispec Ltd. (Israel), STORZ MEDICAL AG (Switzerland), Zimmer Biomet Holdings, Inc. (United States), Promedon S.A. (Argentina), Augusta Medical Systems LLC (United States), Owen Mumford Ltd. (United Kingdom), Zephyr Surgical Implants (Switzerland), UroMed Technology (United States)